Clinical Trials · NCT00104741

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
UNICANCER
Enrollment
378
Start date
Sep 2003
Locations
31 sites, France
Primary endpoint
Impact of complete androgen blockade for 4 months
View Gonadorelin compound reference